Privacy Policy
Signals Blog

Contributors

Categories

Cal Strode

Cal Strode is a communications consultant specializing in health, science, and innovation, with experience in these sectors across the UK, Canada, and U.S. Previously, he was the Manager, Communications at CCRM. Before that, he worked with the UK’s National Institute for Health Research (NIHR) Applied Research Collaboration North West Coast (ARC NWC) and UK Research & Innovation’s (UKRI) 3DBioNet network. He also has five years of public health communications experience, delivering national campaigns with measurable impact in the fields of mental and sexual health. With an interest in how effective communications can catalyze change, his undergraduate thesis on the topic won the European Public Relations Education and Research Association (EUPRERA) award, which led to him presenting his findings at EUPRERA’s congress in Brussels. Outside of work, he enjoys surfing and open-water swimming. Follow him on X @CalStrode.

Posts by: Cal


A foray into the future: Predictions for the year 2050

Author: Cal Strode, 05/26/22

In part 1 of this feature marking the 10-year anniversary of Signals, we got to know the people behind the posts a little better. Now, we’re looking to the future of regenerative medicine and science with the help of our contributors. In this post, bloggers Lyla El-Fayomi, David Kent and Sara Nolte are joined by CCRM leaders Dr. […]

Marking a decade of Signals: Get to know the people behind the posts

Author: Cal Strode, 05/18/22

To mark Signals’ 10-year anniversary, we caught up with some of our active current bloggers — Lyla El-Fayomi, David Kent and Sara Nolte — to get to know them a little better, talk science communication and, in next week’s follow-up post, predict what a science-enabled utopia of the future might look like. Who is your […]

Comparing two snapshots of RM taken a decade apart

Author: Cal Strode, 05/11/22

When Signals first burst onto the scene in 2012, the potential of the regenerative medicine industry still hadn’t set in for many. When the Alliance for Regenerative Medicine (ARM) published its first state of the industry report in 2012, the ARM chairman at the time, Gil Van Bokkelen, wrote that “few people have the desire […]

In the court of public opinion, patient stories pave the way for RM

Author: Cal Strode, 03/10/22

“It’s the need to value balance and respect for life with the promise of science,” former U.S. President George W. Bush argued when announcing his controversial policy blocking federal funding for embryonic stem cell research at a 2001 press conference. The ban acted as a catalyst, bringing patients, caregivers and scientists together in protest. Celebrities […]

World AIDS Day: exploring HIV cure research and gene therapies

Author: Cal Strode, 12/01/21

To mark World AIDS Day, I caught up with the International AIDS Society (IAS) 2021 HIV Cure and Gene Therapy Forum’s opening session, which focused on the intersection between HIV cure research and rapidly advancing gene-based therapies. The session sought to address two increasingly urgent questions: How can advances in gene therapy from other fields […]